Singapore, Jan 04, 2012: International pharma company, ViroPharma has announced the appointment of Ms Julie H McHugh to its board of directors.

Ms McHugh brings a wealth of pharmaceutical and health care industry experience and leadership to ViroPharma's Board of Directors.  She is currently the chief operating officer of Endo Pharmaceuticals, a US-based, specialty healthcare solutions company. Prior to joining Endo, Ms McHugh was chief executive officer of Nora Therapeutics, a biotech company focused on the treatment of infertility disorders. Prior to joining Nora Therapeutics, she was company group chairman for Johnson & Johnson's Worldwide Virology Business Unit and prior to this role she served as president of Centocor, a J&J subsidiary.

"We are very enthusiastic about the addition of Julie to our board," commented Mr Vincent Milano, president and chief executive officer of ViroPharma. "Julie's experience and insight gained from years of pharmaceutical leadership at a number of successful organizations will play a critical role in helping guide our company through our next levels of growth and achievement." 

"I am excited to have the opportunity to serve on the board of directors of ViroPharma; I am impressed by the success that the company has achieved and look forward to taking part in guiding the company towards future growth and successes in the years ahead" commented Ms McHugh.